Research ArticleClinical Studies
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO and YASUHIRO SHIMADA
Anticancer Research April 2021, 41 (4) 2203-2207; DOI: https://doi.org/10.21873/anticanres.14996
YUSUKE NIISATO
1Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
TOSHIKAZU MORIWAKI
1Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
SHOTA FUKUOKA
2Division of Experimental Therapeutics, National Cancer Center, Kashiwa, Japan;
TOSHIKI MASUISHI
3Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan;
ATSUO TAKASHIMA
4Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan;
YOSUKE KUMEKAWA
5Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan;
TAKESHI KAJIWARA
6Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan;
KENTARO YAMAZAKI
7Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan;
TAITO ESAKI
8Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan;
AKITAKA MAKIYAMA
9Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan;
TADAMICHI DENDA
10Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan;
YUKIMASA HATACHI
11Division of Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan;
TAKESHI SUTO
12Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan;
NAOTOSHI SUGIMOTO
13Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan;
YASUHIRO SHIMADA
14Clinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan
In this issue
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO, YASUHIRO SHIMADA
Anticancer Research Apr 2021, 41 (4) 2203-2207; DOI: 10.21873/anticanres.14996
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO, YASUHIRO SHIMADA
Anticancer Research Apr 2021, 41 (4) 2203-2207; DOI: 10.21873/anticanres.14996
Jump to section
Related Articles
- No related articles found.